Vertex Pharmaceuticals Inc. closed $45.72 below its 52-week high ($510.64), which the company achieved on August 1st.

Dividend stocks offer long-term investors unique benefits.

Shares of Vertex Pharmaceuticals Inc. VRTX inched 0.79% higher to $477.90 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising ...

In a report released today, Brian Abrahams from RBC Capital maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report), ...

View Vertex Pharmaceuticals Incorporated (VRTX) current and estimated P/E ratio data provided by Seeking Alpha.

Vertex reported revenues of $2.65 billion in the last reported quarter, representing a year-over-year change of +6.1%. EPS of -$12.83 for the same period compares with $3.89 a year ago.

Sept. 16, 2024 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ:VERX) (“Vertex” or the “Company”), a global provider of tax technology solutions, has been announced at Oracle CloudWorld the winner ...

In a recent transaction, Jeffrey M. Leiden, the Executive Chairman of Vertex Pharmaceuticals Inc. (NASDAQ:VRTX), sold 3,784 shares of company stock. The transaction, dated August 30, 2024 ...

HOUSTON (AP) — Vertex Energy Inc. VTNR) on Thursday reported a loss of $53.8 million in its second quarter. The Houston-based company said it had a loss of 58 cents per share. HOUSTON ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...